- Home
- GDHG vs KYNB Comparison
GDHG vs KYNB Comparison
Compare GDHG & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDHG | KYNB |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 31.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDHG | KYNB |
|---|---|---|
| Price | $1.71 | $7.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 10.7K |
| Earning Date | 07-11-2025 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $6.32 |
| 52 Week High | $8.69 | $9.58 |
Technical Indicators
Market Signals| Indicator | GDHG | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 40.22 | 48.06 |
| Support Level | $1.59 | $7.04 |
| Resistance Level | $1.97 | $7.50 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 23.26 | 18.18 |
Price Performance
Historical ComparisonAbout GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.